Global Rifaximin API Market Growth 2022-2028
- LP 4861172
- 91 Pages
- February 2022
- Pharmaceuticals
The United States Rifaximin API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rifaximin API market, reaching US$ million by the year 2028. As for the Europe Rifaximin API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rifaximin API players cover Salix Pharmaceuticals, Lupin, LGM Pharma, and B Joshi Agrochem Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rifaximin API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
99% Purity
>99% Purity
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pharmaceuticals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Salix Pharmaceuticals
Lupin
LGM Pharma
B Joshi Agrochem Pharma
Triveni Interchem
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rifaximin API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rifaximin API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rifaximin API by Country/Region, 2017, 2022 & 2028
2.2 Rifaximin API Segment by Type
2.2.1 99% Purity
2.2.2 >99% Purity
2.3 Rifaximin API Sales by Type
2.3.1 Global Rifaximin API Sales Market Share by Type (2017-2022)
2.3.2 Global Rifaximin API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rifaximin API Sale Price by Type (2017-2022)
2.4 Rifaximin API Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Others
2.5 Rifaximin API Sales by Application
2.5.1 Global Rifaximin API Sale Market Share by Application (2017-2022)
2.5.2 Global Rifaximin API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rifaximin API Sale Price by Application (2017-2022)
3 Global Rifaximin API by Company
3.1 Global Rifaximin API Breakdown Data by Company
3.1.1 Global Rifaximin API Annual Sales by Company (2020-2022)
3.1.2 Global Rifaximin API Sales Market Share by Company (2020-2022)
3.2 Global Rifaximin API Annual Revenue by Company (2020-2022)
3.2.1 Global Rifaximin API Revenue by Company (2020-2022)
3.2.2 Global Rifaximin API Revenue Market Share by Company (2020-2022)
3.3 Global Rifaximin API Sale Price by Company
3.4 Key Manufacturers Rifaximin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rifaximin API Product Location Distribution
3.4.2 Players Rifaximin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rifaximin API by Geographic Region
4.1 World Historic Rifaximin API Market Size by Geographic Region (2017-2022)
4.1.1 Global Rifaximin API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rifaximin API Annual Revenue by Geographic Region
4.2 World Historic Rifaximin API Market Size by Country/Region (2017-2022)
4.2.1 Global Rifaximin API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rifaximin API Annual Revenue by Country/Region
4.3 Americas Rifaximin API Sales Growth
4.4 APAC Rifaximin API Sales Growth
4.5 Europe Rifaximin API Sales Growth
4.6 Middle East & Africa Rifaximin API Sales Growth
5 Americas
5.1 Americas Rifaximin API Sales by Country
5.1.1 Americas Rifaximin API Sales by Country (2017-2022)
5.1.2 Americas Rifaximin API Revenue by Country (2017-2022)
5.2 Americas Rifaximin API Sales by Type
5.3 Americas Rifaximin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rifaximin API Sales by Region
6.1.1 APAC Rifaximin API Sales by Region (2017-2022)
6.1.2 APAC Rifaximin API Revenue by Region (2017-2022)
6.2 APAC Rifaximin API Sales by Type
6.3 APAC Rifaximin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rifaximin API by Country
7.1.1 Europe Rifaximin API Sales by Country (2017-2022)
7.1.2 Europe Rifaximin API Revenue by Country (2017-2022)
7.2 Europe Rifaximin API Sales by Type
7.3 Europe Rifaximin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rifaximin API by Country
8.1.1 Middle East & Africa Rifaximin API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rifaximin API Revenue by Country (2017-2022)
8.2 Middle East & Africa Rifaximin API Sales by Type
8.3 Middle East & Africa Rifaximin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rifaximin API
10.3 Manufacturing Process Analysis of Rifaximin API
10.4 Industry Chain Structure of Rifaximin API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rifaximin API Distributors
11.3 Rifaximin API Customer
12 World Forecast Review for Rifaximin API by Geographic Region
12.1 Global Rifaximin API Market Size Forecast by Region
12.1.1 Global Rifaximin API Forecast by Region (2023-2028)
12.1.2 Global Rifaximin API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rifaximin API Forecast by Type
12.7 Global Rifaximin API Forecast by Application
13 Key Players Analysis
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Rifaximin API Product Offered
13.1.3 Salix Pharmaceuticals Rifaximin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
13.2 Lupin
13.2.1 Lupin Company Information
13.2.2 Lupin Rifaximin API Product Offered
13.2.3 Lupin Rifaximin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Lupin Main Business Overview
13.2.5 Lupin Latest Developments
13.3 LGM Pharma
13.3.1 LGM Pharma Company Information
13.3.2 LGM Pharma Rifaximin API Product Offered
13.3.3 LGM Pharma Rifaximin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 LGM Pharma Main Business Overview
13.3.5 LGM Pharma Latest Developments
13.4 B Joshi Agrochem Pharma
13.4.1 B Joshi Agrochem Pharma Company Information
13.4.2 B Joshi Agrochem Pharma Rifaximin API Product Offered
13.4.3 B Joshi Agrochem Pharma Rifaximin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 B Joshi Agrochem Pharma Main Business Overview
13.4.5 B Joshi Agrochem Pharma Latest Developments
13.5 Triveni Interchem
13.5.1 Triveni Interchem Company Information
13.5.2 Triveni Interchem Rifaximin API Product Offered
13.5.3 Triveni Interchem Rifaximin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Triveni Interchem Main Business Overview
13.5.5 Triveni Interchem Latest Developments
14 Research Findings and Conclusion
Table 1. Rifaximin API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rifaximin API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 99% Purity
Table 4. Major Players of >99% Purity
Table 5. Global Rifaximin API Sales by Type (2017-2022) & (Kiloton)
Table 6. Global Rifaximin API Sales Market Share by Type (2017-2022)
Table 7. Global Rifaximin API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Rifaximin API Revenue Market Share by Type (2017-2022)
Table 9. Global Rifaximin API Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Rifaximin API Sales by Application (2017-2022) & (Kiloton)
Table 11. Global Rifaximin API Sales Market Share by Application (2017-2022)
Table 12. Global Rifaximin API Revenue by Application (2017-2022)
Table 13. Global Rifaximin API Revenue Market Share by Application (2017-2022)
Table 14. Global Rifaximin API Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Rifaximin API Sales by Company (2020-2022) & (Kiloton)
Table 16. Global Rifaximin API Sales Market Share by Company (2020-2022)
Table 17. Global Rifaximin API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Rifaximin API Revenue Market Share by Company (2020-2022)
Table 19. Global Rifaximin API Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Rifaximin API Producing Area Distribution and Sales Area
Table 21. Players Rifaximin API Products Offered
Table 22. Rifaximin API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rifaximin API Sales by Geographic Region (2017-2022) & (Kiloton)
Table 26. Global Rifaximin API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Rifaximin API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Rifaximin API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Rifaximin API Sales by Country/Region (2017-2022) & (Kiloton)
Table 30. Global Rifaximin API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Rifaximin API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Rifaximin API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Rifaximin API Sales by Country (2017-2022) & (Kiloton)
Table 34. Americas Rifaximin API Sales Market Share by Country (2017-2022)
Table 35. Americas Rifaximin API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Rifaximin API Revenue Market Share by Country (2017-2022)
Table 37. Americas Rifaximin API Sales by Type (2017-2022) & (Kiloton)
Table 38. Americas Rifaximin API Sales Market Share by Type (2017-2022)
Table 39. Americas Rifaximin API Sales by Application (2017-2022) & (Kiloton)
Table 40. Americas Rifaximin API Sales Market Share by Application (2017-2022)
Table 41. APAC Rifaximin API Sales by Region (2017-2022) & (Kiloton)
Table 42. APAC Rifaximin API Sales Market Share by Region (2017-2022)
Table 43. APAC Rifaximin API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Rifaximin API Revenue Market Share by Region (2017-2022)
Table 45. APAC Rifaximin API Sales by Type (2017-2022) & (Kiloton)
Table 46. APAC Rifaximin API Sales Market Share by Type (2017-2022)
Table 47. APAC Rifaximin API Sales by Application (2017-2022) & (Kiloton)
Table 48. APAC Rifaximin API Sales Market Share by Application (2017-2022)
Table 49. Europe Rifaximin API Sales by Country (2017-2022) & (Kiloton)
Table 50. Europe Rifaximin API Sales Market Share by Country (2017-2022)
Table 51. Europe Rifaximin API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Rifaximin API Revenue Market Share by Country (2017-2022)
Table 53. Europe Rifaximin API Sales by Type (2017-2022) & (Kiloton)
Table 54. Europe Rifaximin API Sales Market Share by Type (2017-2022)
Table 55. Europe Rifaximin API Sales by Application (2017-2022) & (Kiloton)
Table 56. Europe Rifaximin API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Rifaximin API Sales by Country (2017-2022) & (Kiloton)
Table 58. Middle East & Africa Rifaximin API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Rifaximin API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Rifaximin API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rifaximin API Sales by Type (2017-2022) & (Kiloton)
Table 62. Middle East & Africa Rifaximin API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Rifaximin API Sales by Application (2017-2022) & (Kiloton)
Table 64. Middle East & Africa Rifaximin API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Rifaximin API
Table 66. Key Market Challenges & Risks of Rifaximin API
Table 67. Key Industry Trends of Rifaximin API
Table 68. Rifaximin API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Rifaximin API Distributors List
Table 71. Rifaximin API Customer List
Table 72. Global Rifaximin API Sales Forecast by Region (2023-2028) & (Kiloton)
Table 73. Global Rifaximin API Sales Market Forecast by Region
Table 74. Global Rifaximin API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Rifaximin API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Rifaximin API Sales Forecast by Country (2023-2028) & (Kiloton)
Table 77. Americas Rifaximin API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Rifaximin API Sales Forecast by Region (2023-2028) & (Kiloton)
Table 79. APAC Rifaximin API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Rifaximin API Sales Forecast by Country (2023-2028) & (Kiloton)
Table 81. Europe Rifaximin API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Rifaximin API Sales Forecast by Country (2023-2028) & (Kiloton)
Table 83. Middle East & Africa Rifaximin API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Rifaximin API Sales Forecast by Type (2023-2028) & (Kiloton)
Table 85. Global Rifaximin API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Rifaximin API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Rifaximin API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Rifaximin API Sales Forecast by Application (2023-2028) & (Kiloton)
Table 89. Global Rifaximin API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Rifaximin API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Rifaximin API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Salix Pharmaceuticals Basic Information, Rifaximin API Manufacturing Base, Sales Area and Its Competitors
Table 93. Salix Pharmaceuticals Rifaximin API Product Offered
Table 94. Salix Pharmaceuticals Rifaximin API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Salix Pharmaceuticals Main Business
Table 96. Salix Pharmaceuticals Latest Developments
Table 97. Lupin Basic Information, Rifaximin API Manufacturing Base, Sales Area and Its Competitors
Table 98. Lupin Rifaximin API Product Offered
Table 99. Lupin Rifaximin API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. Lupin Main Business
Table 101. Lupin Latest Developments
Table 102. LGM Pharma Basic Information, Rifaximin API Manufacturing Base, Sales Area and Its Competitors
Table 103. LGM Pharma Rifaximin API Product Offered
Table 104. LGM Pharma Rifaximin API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. LGM Pharma Main Business
Table 106. LGM Pharma Latest Developments
Table 107. B Joshi Agrochem Pharma Basic Information, Rifaximin API Manufacturing Base, Sales Area and Its Competitors
Table 108. B Joshi Agrochem Pharma Rifaximin API Product Offered
Table 109. B Joshi Agrochem Pharma Rifaximin API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. B Joshi Agrochem Pharma Main Business
Table 111. B Joshi Agrochem Pharma Latest Developments
Table 112. Triveni Interchem Basic Information, Rifaximin API Manufacturing Base, Sales Area and Its Competitors
Table 113. Triveni Interchem Rifaximin API Product Offered
Table 114. Triveni Interchem Rifaximin API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 115. Triveni Interchem Main Business
Table 116. Triveni Interchem Latest Developments
List of Figures
Figure 1. Picture of Rifaximin API
Figure 2. Rifaximin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rifaximin API Sales Growth Rate 2017-2028 (Kiloton)
Figure 7. Global Rifaximin API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rifaximin API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 99% Purity
Figure 10. Product Picture of >99% Purity
Figure 11. Global Rifaximin API Sales Market Share by Type in 2021
Figure 12. Global Rifaximin API Revenue Market Share by Type (2017-2022)
Figure 13. Rifaximin API Consumed in Pharmaceuticals
Figure 14. Global Rifaximin API Market: Pharmaceuticals (2017-2022) & (Kiloton)
Figure 15. Rifaximin API Consumed in Others
Figure 16. Global Rifaximin API Market: Others (2017-2022) & (Kiloton)
Figure 17. Global Rifaximin API Sales Market Share by Application (2017-2022)
Figure 18. Global Rifaximin API Revenue Market Share by Application in 2021
Figure 19. Rifaximin API Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Rifaximin API Revenue Market Share by Company in 2021
Figure 21. Global Rifaximin API Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Rifaximin API Revenue Market Share by Geographic Region in 2021
Figure 23. Global Rifaximin API Sales Market Share by Region (2017-2022)
Figure 24. Global Rifaximin API Revenue Market Share by Country/Region in 2021
Figure 25. Americas Rifaximin API Sales 2017-2022 (Kiloton)
Figure 26. Americas Rifaximin API Revenue 2017-2022 ($ Millions)
Figure 27. APAC Rifaximin API Sales 2017-2022 (Kiloton)
Figure 28. APAC Rifaximin API Revenue 2017-2022 ($ Millions)
Figure 29. Europe Rifaximin API Sales 2017-2022 (Kiloton)
Figure 30. Europe Rifaximin API Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Rifaximin API Sales 2017-2022 (Kiloton)
Figure 32. Middle East & Africa Rifaximin API Revenue 2017-2022 ($ Millions)
Figure 33. Americas Rifaximin API Sales Market Share by Country in 2021
Figure 34. Americas Rifaximin API Revenue Market Share by Country in 2021
Figure 35. United States Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Rifaximin API Sales Market Share by Region in 2021
Figure 40. APAC Rifaximin API Revenue Market Share by Regions in 2021
Figure 41. China Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Rifaximin API Sales Market Share by Country in 2021
Figure 48. Europe Rifaximin API Revenue Market Share by Country in 2021
Figure 49. Germany Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Rifaximin API Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Rifaximin API Revenue Market Share by Country in 2021
Figure 56. Egypt Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Rifaximin API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Rifaximin API in 2021
Figure 62. Manufacturing Process Analysis of Rifaximin API
Figure 63. Industry Chain Structure of Rifaximin API
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
